ZKH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. ZKH is showing weakening downside momentum (bearish MACD expansion) with no supporting catalysts (no news, no proprietary buy signals), and the latest quarter shows deteriorating profitability (larger net loss, EPS down to 0, margin compression). For an impatient buyer who doesn’t want to wait for a cleaner entry, the risk/reward is unattractive at this moment—avoid initiating a new position today.
Trend/Momentum: Bearish. The MACD histogram is below zero (-0.0195) and negatively expanding, signaling downside momentum is still building. RSI(6) is ~28.97, which is near oversold conditions and can allow for a short-term bounce, but it is not enough to override the bearish MACD.
Structure/Levels: Price (3.36) is below the pivot (3.448) and is sitting between S1 (3.38) and S2 (3.337), meaning it’s trading in/near support. Resistance levels to clear on any bounce are R1 (3.517) and R2 (3.56). Moving averages are converging, which often precedes a larger move; with MACD negative, the current bias is still skewed downward until price reclaims the pivot.
Probabilistic near-term bias (given pattern set): modest upside expectations (next day ~+0.49%, next week ~+2.33%, next month ~+4.86%), but these are relatively small and do not negate the current bearish momentum signal.
Intellectia Proprietary Trading Signals
Near-term technical support zone: trading near S2 (3.
can spark a reflex bounce if buyers defend support.
RSI near oversold can enable a short-lived rebound if selling pressure eases.
Statistical pattern outlook suggests mild positive drift over 1 week to 1 month (though not strong enough to be a primary catalyst).
Momentum is still bearish: MACD histogram is negative and expanding, indicating continued downside pressure.
No event-driven support: no news in the past week, implying no fresh catalyst to reverse sentiment.
Price is below pivot (3.448): rallies may get sold into until it reclaims key levels.
Fundamentals weakened in the latest quarter: larger net loss, EPS decline, and margin compression can weigh on sentiment.
Latest reported quarter: 2025/Q3. Revenue rose to 2,328,354,000 (+2.09% YoY), but profitability deteriorated meaningfully: Net income fell to -24,307,000 (-70.27% YoY), EPS dropped to 0 (-100% YoY), and gross margin declined to 16.76% (-1.59% YoY). Overall: modest top-line growth, but worsening earnings and margins—negative quality of growth.
No recent analyst rating changes or price target updates were provided in the data. Wall Street pro/con view cannot be validated from the provided dataset; based on the available fundamentals and technicals, the near-term pro case is an oversold bounce, while the con case is deteriorating profitability alongside bearish momentum.
